Candel Therapeutics (CADL) Institutional Ownership $5.00 +0.24 (+5.04%) As of 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Candel Therapeutics (NASDAQ:CADL)CurrentInstitutional OwnershipPercentage13.93%Number ofInstitutional Buyers(last 12 months)36TotalInstitutional Inflows(last 12 months)$72.05MNumber ofInstitutional Sellers(last 12 months)6TotalInstitutional Outflows(last 12 months)$3.22M Get CADL Insider Trade Alerts Want to know when executives and insiders are buying or selling Candel Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CADL Institutional Buying and Selling by Quarter Candel Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/17/2025 Janney Montgomery Scott LLC21,090$119K0.0%+104.3%0.045% 4/8/2025 Rhumbline Advisers33,302$188K0.0%+26.8%0.071% 2/17/2025Squarepoint Ops LLC19,311$168K0.0%+86.6%0.059% 2/17/2025Nuveen Asset Management LLC68,226$592K0.0%+3.0%0.210% 2/17/2025Maven Securities LTD51,731$449K0.0%N/A0.159% 2/17/2025Millennium Management LLC31,626$275K0.0%+130.6%0.097% 2/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.12,165$106K0.0%+12.4%0.037% 2/17/2025Deutsche Bank AG31,522$274K0.0%+5,814.1%0.097% 2/17/2025Bridgeway Capital Management LLC77,195$670K0.0%-4.2%0.238% 2/17/2025Braidwell LP1,600,000$13.89M0.4%N/A4.926% Get the Latest News and Ratings for CADL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Candel Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/17/2025Baker BROS. Advisors LP2,981,983$25.88M0.3%N/A9.181% 2/17/2025Bank of America Corp DE66,811$580K0.0%+205.6%0.206% 2/17/2025BNP Paribas Financial Markets3,434$30K0.0%N/A0.011% 2/17/2025Acorn Capital Advisors LLC1,939,644$16.84M9.2%N/A5.972% 2/14/2025Northern Trust Corp165,021$1.43M0.0%+3.9%0.508% 2/14/2025Oxford Asset Management LLP12,003$104K0.1%N/A0.037% 2/14/2025Birchview Capital LP60,000$521K0.4%N/A0.185% 2/14/2025Heights Capital Management Inc.30,000$260K0.1%N/A0.092% 2/14/2025MetLife Investment Management LLC13,773$120K0.0%+9.7%0.042% 2/13/2025Portolan Capital Management LLC753,745$6.54M0.4%N/A2.321% 2/13/2025Barclays PLC34,317$297K0.0%+19.6%0.106% 2/13/2025Russell Investments Group Ltd.3,753$33K0.0%+75.1%0.012% 2/13/2025Wells Fargo & Company MN10,122$88K0.0%+63.6%0.031% 2/12/2025Geode Capital Management LLC455,424$3.95M0.0%+1.4%1.402% 2/12/2025JPMorgan Chase & Co.10,426$90K0.0%+15.2%0.032% 2/11/2025LPL Financial LLC10,703$93K0.0%N/A0.033% 2/11/2025Halter Ferguson Financial Inc.681,334$5.91M2.4%+123.7%2.098% 2/10/2025Commonwealth Equity Services LLC41,098$357K0.0%N/A0.127% 2/6/2025Charles Schwab Investment Management Inc.52,190$453K0.0%+11.6%0.161% 2/5/2025 Oppenheimer & Co. Inc.37,915$329K0.0%N/A0.117% 1/30/2025 Rhumbline Advisers26,272$228K0.0%+17.0%0.081% 1/30/2025Vontobel Holding Ltd.19,000$165K0.0%-13.6%0.058% 1/15/2025HB Wealth Management LLC87,300$696K0.0%+54.1%0.269% 12/26/2024JPMorgan Chase & Co.9,051$63K0.0%-53.2%0.028% 11/19/2024Barclays PLC28,688$199K0.0%+327.1%0.088% 11/16/2024Geode Capital Management LLC448,997$3.11M0.0%+12.8%1.399% 11/15/2024Barclays PLC28,688$199K0.0%+327.1%0.089% 11/15/2024MML Investors Services LLC22,313$155K0.0%-69.6%0.070% 11/15/2024State Street Corp492,005$3.41M0.0%+4.1%1.534% 11/15/2024Atom Investors LP14,873$103K0.0%N/A0.046% Trump’s Bitcoin Reserve is No Accident… (Ad)Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new blockchain development…Just click here to get all the details on this crypto coin now11/14/2024MetLife Investment Management LLC12,558$87K0.0%N/A0.039% 11/13/2024FMR LLC6,573$46K0.0%N/A0.020% 9/16/2024Point72 DIFC Ltd4,927$31K0.0%N/A0.017% 9/16/2024Cubist Systematic Strategies LLC26,121$162K0.0%N/A0.088% 8/14/2024Cubist Systematic Strategies LLC26,121$162K0.0%N/A0.088% 8/14/2024Point72 DIFC Ltd4,927$31K0.0%N/A0.017% 8/13/2024Sands Capital Ventures LLC405,837$2.52M0.8%-50.0%1.364% 8/9/2024Renaissance Technologies LLC20,600$128K0.0%-63.8%0.069% 8/1/2024 Rhumbline Advisers22,985$143K0.0%N/A0.077% 7/26/2024Bank of New York Mellon Corp54,449$338K0.0%N/A0.183% 1/29/2024Baystate Wealth Management LLC76,910$113K0.0%-21.0%0.266% 5/10/2023Resources Investment Advisors LLC.25,428$34K0.0%N/A0.088% 4/25/2023Baystate Wealth Management LLC105,854$143K0.0%N/A0.366% 11/14/2022Point72 Asset Management L.P.403,131$1.27M0.0%-45.7%1.395% 5/6/2022Empirical Asset Management LLC12,000$61K0.1%N/A0.042% 4/26/2022Kestra Advisory Services LLC12,500$64K0.0%N/A0.044% 2/15/2022Northpond Ventures LLC1,935,215$15.13M5.3%N/A6.745% 2/15/2022683 Capital Management LLC40,929$320K0.0%N/A0.143% 11/15/2021Caas Capital Management LP50,000$542K0.0%N/A0.174% 11/15/2021Franklin Resources Inc.1,125,000$12.20M0.0%N/A3.921% 11/9/2021BlackRock Inc.22,326$242K0.0%N/A0.078% (Data available from 1/1/2016 forward) CADL Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CADL shares? During the previous two years, 43 institutional investors and hedge funds held shares of Candel Therapeutics. The most heavily invested institutionals were Baker BROS. Advisors LP ($25.88M), Acorn Capital Advisors LLC ($16.84M), Braidwell LP ($13.89M), Portolan Capital Management LLC ($6.54M), Halter Ferguson Financial Inc. ($5.91M), Geode Capital Management LLC ($3.95M), and State Street Corp ($3.41M).Learn more on CADL's institutional investors. What percentage of Candel Therapeutics stock is owned by institutional investors? 13.93% of Candel Therapeutics stock is owned by institutional investors. Learn more on CADL's institutional investor holdings. Which institutional investors have been buying Candel Therapeutics stock? Of the 38 institutional investors that purchased Candel Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Baker BROS. Advisors LP ($2.98M), Acorn Capital Advisors LLC ($1.94M), Braidwell LP ($1.60M), Portolan Capital Management LLC ($753.75K), Halter Ferguson Financial Inc. ($376.80K), Baystate Wealth Management LLC ($105.85K), and Birchview Capital LP ($60K). How much institutional buying is happening at Candel Therapeutics? Institutional investors have bought a total of 8,508,401 shares in the last 24 months. This purchase volume represents approximately $72.23M in transactions. Which Candel Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Candel Therapeutics stock in the last 24 months: Sands Capital Ventures LLC ($405.90K), MML Investors Services LLC ($51.06K), Renaissance Technologies LLC ($36.31K), Baystate Wealth Management LLC ($20.40K), JPMorgan Chase & Co. ($10.31K), Bridgeway Capital Management LLC ($3.40K), and Vontobel Holding Ltd. ($3K). How much institutional selling is happening at Candel Therapeutics? Institutional investors have sold a total of 530,375 shares in the last 24 months. This volume of shares sold represents approximately $3.25M in transactions. Related Companies SNDX Institutional Ownership WVE Institutional Ownership MLYS Institutional Ownership ETNB Institutional Ownership COLL Institutional Ownership DYN Institutional Ownership ELVN Institutional Ownership RCUS Institutional Ownership CMRX Institutional Ownership CDMO Institutional Ownership This page (NASDAQ:CADL) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThe Exact July Date the AI Correction Will End?AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...Brownstone Research | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | SponsoredTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Candel Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Candel Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CADL Stock Free CADL Stock Alerts